Dermatomyositis Images: Clinical Photo Gallery And Key Signs
Comprehensive visual guide to dermatomyositis skin manifestations, symptoms, and clinical features for accurate diagnosis.

Dermatomyositis (DM) is a rare idiopathic inflammatory myopathy characterized by distinctive cutaneous eruptions and proximal muscle weakness. This image gallery showcases the spectrum of skin findings, from pathognomonic rashes to secondary features, aiding in clinical diagnosis and patient education. Images depict classic adult and juvenile presentations, highlighting variability in severity and distribution.
What is dermatomyositis?
Dermatomyositis is an autoimmune disorder primarily affecting skin and skeletal muscles, often involving lungs, heart, and joints. It presents with violaceous rashes on sun-exposed areas and symmetrical proximal muscle weakness in about 77% of cases. Pathognomonic skin signs include heliotrope rash and Gottron’s papules, while muscle involvement may be absent in clinically amyopathic DM (CADM).
Juvenile dermatomyositis (JDM) occurs in children under 18, frequently with calcinosis and less lung disease. Adult DM carries a 25% malignancy risk, necessitating screening. Photosensitivity exacerbates rashes, and pruritus disrupts sleep.
Who gets dermatomyositis?
DM affects all ages and ethnicities, with bimodal peaks: children (5-15 years) and adults (40-60 years). Incidence is 1-10 per million annually, higher in women (2:1 ratio). Genetic factors like HLA-DR3 increase susceptibility. Amyopathic forms comprise 20% of cases.
- Adults: Classic DM with myositis; malignancy-associated in 15-25%.
- Juveniles: JDM without malignancy link; ulceration and lipodystrophy common.
- Amyopathic DM: Skin-only for ≥6 months without weakness.
Clinical features of dermatomyositis
Skin manifestations dominate, often preceding myositis by months. Proximal weakness affects hip girdle (rising from chairs) and shoulders (combing hair). Systemic features include interstitial lung disease (ILD, 30%), arthritis, dysphagia, and fatigue.
Skin findings
Key rashes are photodistributed, violaceous, and itchy. Scalp involvement mimics psoriasis with alopecia.
- Pruritus: Intense, sleep-disturbing itch in 80%.
- Photosensitivity: UV triggers flares.
- Alopecia: Diffuse thinning from scalp inflammation.
Muscle involvement
Symmetrical weakness in 70-80%; elevated CK in classic DM. Myalgia affects 50%.
Systemic features
- ILD: Dyspnea, cough in 20-40%.
- Cardiac: Subclinical abnormalities in 72%.
- GI: Dysphagia from esophageal dysmotility.
- Malignancy: Ovarian, lung, GI cancers in adults.
Pathognomonic skin signs
These highly specific findings confirm DM diagnosis.
Heliotrope rash
Violaceous erythema on eyelids with edema, extending to temples. Seen in 40-60% of patients; pathognomonic with Gottron’s signs.
- Poikilodermatous in chronic cases.
- Images show periorbital purple hue, perioral sparing.
Gottron’s papules
Erythematous-violaceous papules over knuckles (70%), elbows, knees. Scaly, atrophic; pathognomonic.
- Dorsal hand involvement classic.
- Hyperkeratotic in mechanics hands variant.
Gottron’s sign
Flat, erythematous macules over interphalangeal joints, sparing knuckles. Extends to elbows/knees.
Characteristic skin signs
Shawl sign / Holster sign
Diffuse erythema across posterior neck, shoulders, upper back (shawl); lateral thighs (holster). Poikilodermatous, pruritic.
V-sign
Erythema over anterior neck, chest (V-neck distribution). Photodistributed, confluent.
Photosensitive rash
Violaceous on face, scalp, forearms; flagellate linear erythema rare.
Scalp pruritus
Erythematous, scaly scalp with alopecia; psoriasis-like.
Proximal nailfold erythema
Ragged cuticles (Samitz sign), telangiectasia, capillary dropout. Mechanic’s hands: hyperkeratosis on fingers.
Other skin signs
- Poikiloderma: Atrophy, dyspigmentation, telangiectasia on trunk/limbs.
- Calcinosis: Subcutaneous nodules in JDM (30-70%).
- Ulcerations: Rare in adults; vasculopathic in severe disease.
- Lipodystrophy: JDM facial fat loss.
Juvenile dermatomyositis images
JDM features milder myositis but prominent calcinosis, ulceration. Images show periorbital heliotrope, Gottron’s on knees, lipoatrophy.
- Calcinosis universalis: Extensive soft tissue deposits.
- Gutter sign: Ulcers over knuckles.
Clinically amyopathic dermatomyositis
Skin findings without weakness for ≥6 months; high ILD risk. Images mirror classic DM rashes.
Muscle biopsy pathology
Perifascicular atrophy, inflammation. Images reveal vacuolar interface dermatitis, mucin deposition, perivascular infiltrates.
Skin biopsy pathology
Classic: Vacuolar dermatitis, keratinocyte necrosis, dermal mucin, vascular dilatation.
Differential diagnosis
| Condition | Key Differentiators |
|---|---|
| Drug-induced DM | HMG-CoA inhibitors; resolves on discontinuation. |
| Lupus erythematosus | Malar rash spares eyelids; anti-dsDNA+. |
| Polymorphic light eruption | Seasonal, monomorphic papules. |
| Psoriasis | Scalp plaques without heliotrope. |
| Paraneoplastic rashes | Malignancy screen positive. |
Investigations
- Muscle enzymes: CK, aldolase elevated in 70%.
- Autoantibodies: MSA profile (anti-Mi-2, TIF1γ for cancer).
- EMG: Myopathic changes, fibrillations.
- MRI: Muscle edema.
- Biopsy: Skin/muscle confirmation.
- Cancer screen: CT/PET in adults.
Treatment of dermatomyositis
No cure; symptom control via immunosuppression. First-line: Prednisone 1mg/kg + steroid-sparing agent.
- Corticosteroids: High-dose taper.
- Immunosuppressants: MTX, AZA, MMF.
- IVIG: Refractory myositis, dysphagia.
- Biologics: Rituximab for refractory.
- Skin: Hydroxychloroquine, topical steroids.
Anti-Mi-2 dermatomyositis
MSA with classic rashes, good prognosis. Images: Prominent shawl, poikiloderma.
FAQ
What does dermatomyositis look like?
Violet eyelid rash (heliotrope), scaly knuckle papules (Gottron’s), shawl/ V-sign erythema.
Is dermatomyositis itchy?
Yes, severe pruritus in most, especially scalp and photodistributed areas.
Can dermatomyositis be only skin?
Yes, amyopathic DM features rashes without weakness.
Does dermatomyositis cause cancer?
Associated in 25% adults; screen age-appropriately.
How is dermatomyositis diagnosed?
Bohan/Peter criteria: Rash + weakness + enzymes/biopsy/EMG.
References
- Dermatomyositis (DM) – Myositis Support and Understanding — Understanding Myositis. 2023. https://understandingmyositis.org/myositis/dermatomyositis/
- Dermatomyositis: Practical Guidance and Unmet Needs — PMC (NIH). 2024-02-29. https://pmc.ncbi.nlm.nih.gov/articles/PMC10924937/
- How Does Dermatomyositis Affect the Body: A Complete Guide — Harlan MD. 2024. https://harlanmd.com/blogs/smartlotion-blog/how-dermatomyositis-affects-body
- Dermatomyositis – Diagnosis & treatment — Mayo Clinic. 2024-10-01. https://www.mayoclinic.org/diseases-conditions/dermatomyositis/diagnosis-treatment/drc-20353192
- Dermatomyositis (and polymyositis) — PCDS. 2023-06-30. https://www.pcds.org.uk/clinical-guidance/dermatomyositis
Read full bio of medha deb














